Helius Medical Technologies is trading 5.06% higher at $2.75, versus its October 1 close of $2.62; no confirmed October 2 company announcement explains the rise.
- A September 30 announcement priced a $15 million registered direct offering, but reporting does not establish that it caused the October 2 gain.
- Broader indices are also higher, though no direct link to the stock’s move is established.